IL319379A - Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy - Google Patents
Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapyInfo
- Publication number
- IL319379A IL319379A IL319379A IL31937925A IL319379A IL 319379 A IL319379 A IL 319379A IL 319379 A IL319379 A IL 319379A IL 31937925 A IL31937925 A IL 31937925A IL 319379 A IL319379 A IL 319379A
- Authority
- IL
- Israel
- Prior art keywords
- minigastrin
- imaging
- novel
- receptor binding
- binding molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22196630 | 2022-09-20 | ||
| PCT/EP2023/063469 WO2024061483A1 (en) | 2022-09-20 | 2023-05-19 | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319379A true IL319379A (en) | 2025-05-01 |
Family
ID=83994946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319379A IL319379A (en) | 2022-09-20 | 2023-05-19 | Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4590347A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025532619A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250073200A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119907695A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023345654A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3264385A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL319379A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025003151A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024061483A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12642876B1 (en) | 2025-10-30 | 2026-06-02 | Perspective Therapeutics, Inc. | Cholecystokinin-2 receptor targeted compounds and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3412303A1 (en) * | 2017-06-08 | 2018-12-12 | Medizinische Universität Innsbruck | Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy |
| KR20240027896A (ko) * | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| EP4023250A1 (en) * | 2021-01-04 | 2022-07-06 | Technische Universität München | Dual mode radiotracer and -therapeutics |
-
2023
- 2023-05-19 CA CA3264385A patent/CA3264385A1/en active Pending
- 2023-05-19 IL IL319379A patent/IL319379A/en unknown
- 2023-05-19 EP EP23727562.3A patent/EP4590347A1/en active Pending
- 2023-05-19 WO PCT/EP2023/063469 patent/WO2024061483A1/en not_active Ceased
- 2023-05-19 JP JP2025515980A patent/JP2025532619A/ja active Pending
- 2023-05-19 AU AU2023345654A patent/AU2023345654A1/en active Pending
- 2023-05-19 KR KR1020257012384A patent/KR20250073200A/ko active Pending
- 2023-05-19 EP EP25193071.5A patent/EP4631959A3/en active Pending
- 2023-05-19 CN CN202380067423.2A patent/CN119907695A/zh active Pending
-
2025
- 2025-03-18 MX MX2025003151A patent/MX2025003151A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20250073200A (ko) | 2025-05-27 |
| CA3264385A1 (en) | 2024-03-28 |
| CN119907695A (zh) | 2025-04-29 |
| JP2025532619A (ja) | 2025-10-01 |
| AU2023345654A1 (en) | 2025-02-27 |
| WO2024061483A1 (en) | 2024-03-28 |
| MX2025003151A (es) | 2025-04-02 |
| EP4590347A1 (en) | 2025-07-30 |
| EP4631959A3 (en) | 2025-12-17 |
| EP4631959A2 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Demizu et al. | Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy | |
| MX2010001378A (es) | Uso terapeutico de anticuerpos del receptor anti-tweak. | |
| IL280535A (en) | Muscle-directed couplings and their uses in the treatment of Friedreich's ataxia | |
| CA3264385A1 (en) | NEW MINIGASTRINE-DERIVED CHOLECYSTOKIN 2 RECEPTOR-BINDING MOLECULES FOR TARGETED IMAGING AND RADIOTHERAPY | |
| SA523442921B1 (ar) | جزيئات ربط علاجية | |
| MX2009012749A (es) | Compuestos heterociclicos como moduladores positivos del receptor de glutamato metabotropico 2 (receptor mglu2). | |
| CY1118566T1 (el) | Διαγνωση με χρηση ιντερφερονης τυπου 1 | |
| IL316848A (en) | Antigen-binding molecules targeting SARS-CoV-2 | |
| IL128003A (en) | MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR | |
| MX2007006102A (es) | Agentes anti-cancer de union a tubulina y profarmacos de los mismos. | |
| IL320410A (en) | Combination therapy involving bispecific antibodies containing an NRP1 binding domain | |
| MX2020007167A (es) | Composiciones y metodos para tratar enfermedades metabolicas. | |
| HK40122619A (en) | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | |
| MX2020000673A (es) | Composiciones que contienen conjugados análogos de cannabinoides y métodos de uso. | |
| IL290280A (en) | Estrogen receptor modulators for the treatment of mutants | |
| IL299648A (en) | Anti-interleukin 36 receptor therapy for psoriasis | |
| SMT202400493T1 (it) | Terapia a base di immunoconiugato di tnf-a per il trattamento di tumori cerebrali | |
| IL316017A (en) | Combined treatment for cancer | |
| WO2023150510A3 (en) | Car and polyspecific binding molecules targeting solid tumors | |
| ZA202209478B (en) | Rat fixator for cheek acupuncture | |
| BR112023023284A2 (pt) | Anticorpos para tratamento de alfa-sinucleinopatias | |
| IL298170B1 (en) | Tendon fixation plate | |
| MX2019010732A (es) | Uso de moduladores de receptor de glucocorticoide en el tratamiento de tumores secretores de catecolamina. | |
| KR102467285B9 (ko) | 우황청심환을 포함하는 파킨슨 질환 예방 또는 치료용 약학 조성물 | |
| IL317689A (en) | Binding molecules for cancer treatment |